Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$537M |
| 2 |
Goldman Sachs
GS
|
+$200M |
| 3 |
Intuit
INTU
|
+$149M |
| 4 |
ExxonMobil
XOM
|
+$149M |
| 5 |
Salesforce
CRM
|
+$141M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PFPT
Proofpoint, Inc.
PFPT
|
+$172M |
| 2 |
WORK
Slack Technologies, Inc.
WORK
|
+$169M |
| 3 |
Amazon
AMZN
|
+$158M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$155M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$142M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.54% |
| 2 | Financials | 12.61% |
| 3 | Industrials | 10.64% |
| 4 | Consumer Discretionary | 9.75% |
| 5 | Healthcare | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Regal Rexnord
RRX
$11.1B
| $27.2M | 0.11% |
181,086
+79,061
| +77% | +$11.3M |
|
252
Cigna
CI
$73.3B
| $27.2M | 0.11% |
135,898
+99,645
| +275% | +$21.7M |
|
253
Hartford Financial Services
HIG
$36.9B
| $27.1M | 0.11% |
386,029
-447,152
| -54% | -$29.6M |
|
254
Sensata Technologies
ST
$6.23B
| $27M | 0.11% |
492,852
+370,869
| +304% | +$21.3M |
|
255
Kroger
KR
$35.5B
| $27M | 0.11% |
+666,737
| New | +$28M |
|
|
HIBB
256
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $26.7M | 0.11% |
377,936
+198,117
| +110% | +$17.3M |
|
257
Armstrong World Industries
AWI
$7.55B
| $26.6M | 0.11% |
278,342
+1,917
| +0.7% | +$201K |
|
258
Meta Platforms (Facebook)
META
$1.4T
| $26.5M | 0.11% |
78,133
-54,999
| -41% | -$19.8M |
|
259
CALL
State Street
STT
$51.4B
| $26.3M | 0.11% |
+310,000
| New | +$27M |
|
|
VMW
260
PUT
DELISTED
VMware, Inc
VMW
| $26.2M | 0.11% |
+176,000
| New | +$26.7M |
|
261
Equifax
EFX
$22.6B
| $26M | 0.11% |
102,760
+30,122
| +41% | +$7.83M |
|
|
VER
262
DELISTED
VEREIT, Inc.
VER
| $25.6M | 0.11% |
565,120
-381,633
| -40% | -$18.5M |
|
263
GDS Holdings
GDS
$6.58B
| $25.1M | 0.1% |
442,664
+164,984
| +59% | +$10.2M |
|
264
Hilton Worldwide
HLT
$73.5B
| $24.9M | 0.1% |
188,773
-217,925
| -54% | -$27.5M |
|
265
Cooper Companies
COO
$14.9B
| $24.9M | 0.1% |
+241,188
| New | +$25.7M |
|
266
Sabre
SABR
$848M
| $24.9M | 0.1% |
2,104,229
+964,206
| +85% | +$10.9M |
|
267
CALL
State Street SPDR S&P Biotech ETF
XBI
$11.2B
| $24.7M | 0.1% |
+196,800
| New | +$25.3M |
|
268
Reinsurance Group of America
RGA
$15.9B
| $24.5M | 0.1% |
219,911
+50,728
| +30% | +$5.78M |
|
269
Robert Half
RHI
$4.58B
| $24.4M | 0.1% |
243,405
+52,301
| +27% | +$5.12M |
|
270
Revvity
RVTY
$13.9B
| $24.4M | 0.1% |
140,875
-118,513
| -46% | -$20.9M |
|
|
AYX
271
DELISTED
Alteryx Inc
AYX
| $24.4M | 0.1% |
333,108
+251,705
| +309% | +$18.9M |
|
272
CubeSmart
CUBE
$9.21B
| $24.3M | 0.1% |
501,855
+37,828
| +8% | +$1.91M |
|
|
XLRN
273
DELISTED
Acceleron Pharma
XLRN
| $24.2M | 0.1% |
+140,492
| New | +$18.4M |
|
274
CALL
iShares China Large-Cap ETF
FXI
$4.28B
| $24.1M | 0.1% |
620,000
+591,500
| +2,075% | +$24.4M |
|
275
Donaldson
DCI
$10.8B
| $24.1M | 0.1% |
+419,384
| New | +$27M |
|
Similar funds
Dmitry Balyasny's Q3 2021 Portfolio in Review
As of Q3 2021, Dmitry Balyasny held 2,691 positions worth $24B, up 14% from $21.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Dmitry Balyasny deployed $2.75B of net new capital in Q3 2021, opening 770 new positions and adding to 420 existing holdings. Its largest new stake was Salesforce: 556,949 shares worth $151M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Fortive, an estimated $138M trimmed.
- Dmitry Balyasny's largest Q3 2021 buy was Salesforce: 556,949 shares worth $151M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $537M increase.
- Dmitry Balyasny's biggest Q3 2021 reduction was Fortive, cutting an estimated $138M.
- Dmitry Balyasny fully exited Proofpoint, Inc. in Q3 2021, selling an estimated $172M.
- Dmitry Balyasny's ten largest holdings make up 10% of its $24B portfolio in Q3 2021.
- Dmitry Balyasny opened 770 new positions and closed 817 in Q3 2021.
- Dmitry Balyasny's portfolio value rose 14% quarter-over-quarter to $24B.
Based on Balyasny Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.